 The panel will include an interactive discussion moderated by Jason McCarthy, Ph.D., Maxim Group Senior Managing Director, Biotechnology. Among the topics to be discussed are how cell therapy can treat acute respiratory distress syndrome, or ARDS, a significant contributor to higher mortality in COVID-19. 